Pomalidomide is a derivative of thalidomide. It is anti-angiogenic and also acts as an immunomodulator. Pomalidomide has been approved on February 28, 2013 by the U.S. Food and Drug Administration (FDA) as a treatment for relapsed and refractory multiple myeloma.


Product Name:                  Pomalidomide

Synonyms:                         N/A

CAS Number:                     19171-19-8

Molecular Weight:            273.2476

Molecular Formula:          C13H11N3O4

Purity (HPLC):                     ≥95%

Shipping Conditions:         Room temperature.

Storage Conditions:           Refrigerated.

Regulatory Statement:      For Research Use Only.

SMILES:                               O=C1CCC(C(=O)N1)N1C(=O)c2c(C1=O)c(N)ccc2


  • $277.00
  • Ex Tax: $277.00

Available Options